Multiple myeloma and hyperammonemic encephalopathy: Review of 27 cases

Clinical Lymphoma and Myeloma

Volumn 8, Issue 6, 2008, Pages 363-369

  Lora Tamayo, Jaime ^a   Palom, Xavier ^a   Sarrá, José ^a   Gasch, Oriol ^a   Isern, Virginia ^a   De Sevilla, Alberto Fernández ^a   Pujol, Ramón ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Ammonium; Hyperammonemia; Hypoxemia; Melphalan

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMMONIA; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BORTEZOMIB; CALCIUM; CARNITINE; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ENEMA; ERYTHROPOIETIN; FLUMAZENIL; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN LAMBDA CHAIN; LACTULOSE; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; PROTEIN; UNINDEXED DRUG; UREA; VINCRISTINE; VINDESINE; ZOLEDRONIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMINO ACID SEQUENCE; AMMONIA BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER STAGING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; FLAPPING TREMOR; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERAMMONEMIA; HYPERAMMONEMIC ENCEPHALOPATHY; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOPENIA; LIVER FUNCTION TEST; LUMBAR PUNCTURE; MALE; METABOLIC ENCEPHALOPATHY; MORTALITY; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MYELOFIBROSIS; PORTAL HYPERTENSION; PROTEIN BLOOD LEVEL; RESPIRATORY ALKALOSIS; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE; UREA BLOOD LEVEL; CASE REPORT; CONSCIOUSNESS DISORDER; MIDDLE AGED; REVIEW; TOXICITY AND INTOXICATION;

ADULT; AGED; AGED, 80 AND OVER; CONSCIOUSNESS DISORDERS; FEMALE; HUMANS; HYPERAMMONEMIA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEUROTOXICITY SYNDROMES;

EID: 59649093036     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2008.n.054     Document Type: Article

References (24)

1. Keller DR, Keller K. Hyperammonemic encephalopathy in multiple myeloma. Am J Hematol 1998; 57:264-5.
2. Shah AS, Shetty N, Jaiswal S, et al. Hyperammonemia: an unusual presenting feature of multiple myeloma. Indian J Med Sci 2005; 59:24-7.
3. Takimoto Y, Imanaka F, Hayashi Y, et al. A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy. Leukemia 1996; 10:918-9.
4. Weng TI, Shih FF, Chen WJ. Unusual causes of hyperammonemia in the ED. Am J Emerg Med 2004; 22:105-7.
5. Caminal L, Castellanos E, Mateos V, et al. Hyperammonaemic encephalopathy as the presenting feature of IgD myeloma. J Intern Med 1991; 233:277-9.
6. Fine P, Adler K, Gerstenfeld D. Idiopathic hyperammonemia after high dose chemotherapy. Am J Med 1989; 86:629.
7. Frere P, Canivet JL, Gennigens C, et al. Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplant 2000; 26:343-5.
8. Furer V, Heyd J. Hyperammonemic encephalopathy in multiple myeloma. IMAJ 2007; 9:557-9.
9. Kuribayashi N, Matsukazi H, Hata H, et al. Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure. Am J Hematol 1998; 57:77-81.
10. Kwan L, Wang C, Levitt L. Hyperammonemic encephalopathy in multiple myeloma. N Engl J Med 2002; 346:1674-5.
11. Martinelli G, Peccatori F, Ullrich B, et al. Clinical manifestation of severe hyperammonaemia in patients with multiple myeloma. Ann Onc 1997; 8:811.
12. Matsuzaki H, Hata H, Sonoki T, et al. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int J Haematol 1995; 61:131-7.
13. Matsuzaki H, Uchiba M, Yoshimura K, et al. Hyperammonemia in multiple myeloma. Acta Hematol 1990; 84:130-4.
14. Otsuki T, Nakazawa N, Taniwaki M, et al. Establishment of a new human myeloma cell line, KSM-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from IgA- to BJP-, and associated with hyperammonemia. Int J Onc 1998; 12:545-52.
15. Pérez Reportillo JA, Marco F, Amutio E, et al. Hyperammonemic encephalopathy in multiple myeloma. Haematologica 1998; 83:956-7.
16. Holahan JR. Hyperammonemia: elevated ammonia levels in multiple myeloma. Am J Med 2004; 116:210-1.
17. Cohn RM, Roth KS. Hyperammonemia, bane of the brain. Clin Pediatr (Phila) 2004; 43:683-9.
18. Davies SM, Szabo E, Wagner JE, et al. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transplant 1996; 17:1119-25.
19. Watson AJ, Chambers T, Karp JE, et al. Transient idiopathic hyperammonaemia in adults. Lancet 1985; 2:1271-4.
20. Mitchell RB, Wagner JE, Karp JE, et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1998; 85:662-7.
21. Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest 2007; 132:1368-78.
22. Talamo G, Cavallo F, Zangari M, et al. Hyperammonemia and encephalopathy in patients with multiple myeloma. Am J Hematol 2007; 82:414-5.
23. Otsuki T, Yamada O, Sakaguchi H, et al. In vitro excess ammonia production in human myeloma cell lines. Leukemia 1998; 12:1149-58.
24. Berenson JR, Casciato DA. Plasma cell dyscrasias and Waldenströms macroglobulinemia. In: Casciato DA, ed. Manual of Clinical Oncology 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004, 458-79.